Gazette.govt.nzPursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Clomipramine-Teva |
| Active Ingredient: | Clomipramine hydrochloride 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Teva Operations Poland Sp., Krakow, Poland |
|
This consent is valid for two years from the date of publication of this notice. This consent is given subject to the following condition:
|
|
| Product: | Clomipramine-Teva |
| Active Ingredient: | Clomipramine hydrochloride 25mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | Teva Operations Poland Sp., Krakow, Poland |
|
This consent is valid for two years from the date of publication of this notice. This consent is given subject to the following condition:
|
|
Dated this 9th day of September 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).